University of Minnesota. Driven to Discover.
"The antibiotic resistance pattern of this strain is alarming," a CDC expert says.
Officials are bracing for more cases and spread to new areas after a community protest led to the suspension of Ebola response activities.
Lefamulin approval was supported by two phase 3 trials involving moxifloxacin.
Postprescription audit and review showed more promise than preauthorization.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.